This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Roche has agreed to acquire PathAI, a Boston-based digital ...

Roche has signed a definitive merger agreement for the acquisition of US-based PathAI in a deal valued at up to $1.05bn. PathAI specialises in digital pathology and AI-powered diagnostics, serving ...

Roche RHHBY said Wednesday it will acquire U.S.-based digital pathology and AI company PathAI in a deal worth up to $1.05 billion, including milestone payments. The acquisition will expand Roche's ...

TUCSON, Ariz., June 18, 2024 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its whole-slide imaging system, the Roche Digital Pathology Dx (VENTANA DP 200), has received 510(k ...

It’s only been a few months since Roche started inviting artificial intelligence developers like Fierce 15 honoree PathAI into its cancer-focused digital pathology platform, but it’s already going all ...

PathAI, maker of AI-enabled pathology products, announced Friday it was partnering with pharma and diagnostics giant Roche. The strategic partnership will allow PathAI to develop and distribute its AI ...

Roche's navify Digital Pathology software platform now offers Ibex's Artificial Intelligence (AI) algorithms to support clinicians in the diagnosis of breast and prostate cancer. Roche and Ibex ...

Pharmaceutical company Roche announced the expansion of its digital pathology open environment by integrating more than 20 advanced artificial intelligence algorithms from eight new collaborators. The ...